Analgesic Adverse Reaction, Inhalation; Vapor, Nociceptive Pain
Conditions
Brief summary
This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.
Detailed description
This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the analgesia effect of the sevoflurane. And test the correlation between the sevoflurane and NOX index.
Interventions
DEVICEnociception index qNOX
non-invasive, real time, monitoring for nociception stimulation
Sponsors
China International Neuroscience Institution
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
25 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
1. Elective thoracoscope surgery patients 2. Age ranging from 25 to 85 years 3. American Society of Anesthesiologists (ASA) Physical Status score of 2 to 4 4. a body mass index (BMI) ranging from 18.5 to 40 kg/m2.
Exclusion criteria
1. Clinical diagnosis of Alzheimer's Disease 2. implanted pacemaker 3. Clinical diagnosis of psychiatric diseases 4. Clinical diagnosis of epilepsy 5. Clinical diagnosis of autonomic nervous system disorders which might affect the EEG
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The sevoflurane application correlated with the qNOX index | through study completion, an average of 1 year | The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application |
Countries
China
Outcome results
None listed